Literature DB >> 8449058

Catecholamines and blood pressure in obstructive sleep apnea syndrome.

O Marrone1, L Riccobono, A Salvaggio, A Mirabella, A Bonanno, M R Bonsignore.   

Abstract

To evaluate the release of catecholamines and their relationship with systemic blood pressure (BP) in normotensive patients with obstructive sleep apnea syndrome (OSAS), diurnal and nocturnal urinary norepinephrine (NE) and epinephrine (E) excretion in 12 normal subjects and in 10 OSAS patients were compared; in addition, nocturnal NE and E excretion were measured in the patients while receiving short-term CPAP. Blood pressure was continuously monitored in the patients during both nights of urine collection. In normal subjects, both NE and E excretion decreased from day to night. In the patients without CPAP, only NE excretion decreased at night, and BP increased from wakefulness to sleep; both NE and E excretion were higher in patients than in normal subjects. With CPAP, which prevented apneas, only E excretion decreased with respect to the previous night, while BP no longer increased during sleep. The extent of nocturnal E decrease with CPAP was not correlated to BP variations. These results suggest that in normotensive OSAS subjects, sympathetic nervous system activity, based on NE excretion, is continuously increased and is not affected by short-term CPAP treatment. Conversely, adrenal activity, based on E excretion, is also increased, but it tends to be normalized by short-term CPAP. No clear relationship could be found between sympatho-adrenal behavior and BP during sleep.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449058     DOI: 10.1378/chest.103.3.722

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  56 in total

Review 1.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

Review 2.  Sympatho-adrenal activation by chronic intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar; Ying-Jie Peng
Journal:  J Appl Physiol (1985)       Date:  2012-06-21

Review 3.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

4.  Self-reported snoring and metabolic syndrome: the Korean Multi-Rural Communities Cohort Study.

Authors:  Min-Ho Shin; Sun-Seog Kweon; Bo Youl Choi; Mi Kyung Kim; Byung-Yeol Chun; Dong Hoon Shin; Young-Hoon Lee
Journal:  Sleep Breath       Date:  2013-11-06       Impact factor: 2.816

5.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

6.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

7.  Saliva production and surface tension: influences on patency of the passive upper airway.

Authors:  J C M Lam; K Kairaitis; M Verma; J R Wheatley; T C Amis
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

Review 8.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 9.  Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism.

Authors:  Ajibola Monsur Adedayo; Oladipupo Olafiranye; David Smith; Alethea Hill; Ferdinand Zizi; Clinton Brown; Girardin Jean-Louis
Journal:  Sleep Breath       Date:  2012-08-18       Impact factor: 2.816

Review 10.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.